Prof. Chong obtained his MPhil and PhD in Immunology from the Department of Paediatrics and Adolescent Medicine at The University of Hong Kong. He received his postdoctoral training in immunology from the National Eye Institute at National Institutes of Health (NIH) in Bethesda, MD, USA. After that, he was appointed as the Associate Professor at the Key State Laboratory of Ophthalmology, Sun Yat-sen University in Guangzhou, China. He joined the School of Chinese Medicine, Hong Kong Baptist University, as the Associate Professor in 2022.

Dr. Chong's research centers on the cellular and molecular mechanism involved in immunoregulation and autoimmunity, and discovering novel therapeutic drug for autoimmune diseases. His works on autoimmunity have been well recognized and published in prestigious journals, including Immunity, Journal of Experimental Medicine, Journal of Autoimmunity, Hepatology and Journal of Infection.

Prof. Chong’s interest is in cellular and molecular mechanisms involved in regulating immune responses in autoimmune diseases. To better dissect the basic mechanisms involved, we used various animal models, including experimental autoimmune encephalomyelitis (EAE) and experimental autoimmune uveitis (EAU) to understand the disease pathogenesis. The goal is to translate our observations from these studies for the development of novel approaches for immunotherapy.

莊教授於香港大學兒科學系取得免疫學哲學碩士及博士學位，其後於美國國立衛生研究院（NIH）轄下的國家眼科研究所（NEI）接受免疫學博士後培訓。完成培訓後，他獲聘為中國廣州中山大學眼科中心眼科學國家重點實驗室副教授，並於2022年加入香港浸會大學中醫藥學院擔任副教授。

莊教授的研究聚焦於免疫調節與自身免疫疾病的細胞及分子機制，並致力發掘治療自身免疫疾病的新型藥物。他在自身免疫領域的研究成果備受認可，並發表於多份知名期刊，包括《Immunity》、《Journal of Experimental Medicine》、《Journal of Autoimmunity》、《Hepatology》及《Journal of Infection》。

莊教授的研究興趣在於探索自身免疫疾病中調控免疫反應的細胞及分子機制。為深入剖析相關基礎機制，其團隊運用多種動物模型，如實驗性自身免疫性腦脊髓炎（EAE）及實驗性自身免疫性葡萄膜炎（EAU），以解析疾病發病機制。研究目標是將這些基礎研究的發現轉化為新型免疫治療策略的開發。